AVX Pharma
VerifiedDeveloping novel drugs addressing major ophthalmic unmet medical needs, with especial focus on ocular surface diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$11—17m (Dealroom.co estimates Oct 2014.)
Barcelona Catalonia (HQ & founding location)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | $0.0 | round | |
| investor | $0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
Related Content
Recent News about AVX Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.